Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Press releases
Get the latest updates from Press releases directly as they happen.
Follow now 560 followers
Latest posts
Last updated about 17 hours ago
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
1 day ago
Blenrep is the only anti-BCMA accessible in the community setting where 70%...
GSK announces positive pivotal phase III data for next-generation low carbon version of Ventolin (salbutamol) metered dose inhaler
2 days ago
Data confirm therapeutic equivalence and comparable safety profile for Ventolin (salbutamol) containing...
Positive PIVOT-PO phase III data show tebipenem HBr’s potential as the first oral carbapenem antibiotic for patients with complicated urinary tract infections (cUTIs)
3 days ago
Data presented at IDWeek 2025 after study stopped early for efficacy
GSK’s Shingrix new prefilled syringe presentation receives positive CHMP opinion
3 days ago
Prefilled syringe offers a convenient ready-to-use administration option to healthcare professionals.
Global Fund welcomes renewed commitment from GSK and ViiV Healthcare to expand community-led health solutions with £6 million joint pledge ahead of 8th Replenishment
4 days ago
The Global Fund to Fight AIDS, Tuberculosis and Malaria today welcomed a...
ViiV Healthcare’s CLARITY study shows long-acting cabotegravir more acceptable than lenacapavir injections after a single dose, with 90% preferring cabotegravir
9 days ago
Findings could help inform expectations and decision-making when initiating long-acting HIV injectables
GSK’s Shingrix approved in China for prevention of shingles in adults aged 18 and over who are at increased risk due to immunodeficiency or immunosuppression
10 days ago
Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) is the first and only...
Luke Miels appointed CEO designate for GSK
25 days ago
Luke to assume full responsibilities as CEO from 1st January 2026
GSK to submit label update for Wellcovorin (leucovorin) at US FDA’s request
about 1 month ago
GSK confirmed today that it will submit a supplemental New Drug Application...
GSK to invest $30 billion in R&D and Manufacturing in the United States over next 5 years
about 1 month ago
New facilities will bridge R&D and manufacturing across both the US and...
GSK to showcase new research from its broad respiratory portfolio at the European Respiratory Society (ERS) Congress 2025
about 1 month ago
60+ abstracts highlight GSK ambition in respiratory diseases to reduce exacerbations, prevent...
Gepotidacin accepted for priority review by the US FDA for the oral treatment of uncomplicated urogenital gonorrhoea
2 months ago
Submission supported by positive phase III data in patients with uncomplicated urogenital...